The first study that identified TMIGD1 as a putative tumor suppressor is based on a systematic comparative transcriptome analysis of normal colonic tissue, precancerous non-polypoid lesions, pre-cancerous polypoid lesions, and colorectal cancer (CRC) lesions [16]. This evidence concerns the gene TMIGD1 and colorectal cancer.